Juxtacrine and paracrine interactions of rat marrow-derived mesenchymal stem cells, muscle-derived satellite cells, and neonatal cardiomyocytes with endothelial cells in angiogenesis dynamics

Stem Cells and Development

Volumn 22, Issue 6, 2013, Pages 855-865

  Rahbarghazi, Reza ^a   Nassiri, Seyed Mahdi ^a   Khazraiinia, Parvaneh ^a   Kajbafzadeh, Abdol Mohammad ^b   Ahmadi, Seyed Hossein ^c   Mohammadi, Elham ^a   Molazem, Mohammad ^a   Zamani Ahmadmahmudi, Mohamad ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; FIBROBLAST GROWTH FACTOR 2; MATRIGEL; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION AND CELL CONTACT; CELL CULTURE; CELL ELONGATION; CELL STRUCTURE; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SATELLITE CELL; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CHEMOTAXIS; COCULTURE TECHNIQUES; COLLAGEN; CULTURE MEDIA, CONDITIONED; DRUG COMBINATIONS; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; LAMININ; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PROTEOGLYCANS; RATS; SATELLITE CELLS, SKELETAL MUSCLE; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84876250598     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0377     Document Type: Article

References (41)

1. Aguirre A, J Planell and E Engel. (2010). Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. Biochem Biophys Res Commun 400:284-291.
2. Wiley DM, J-D Kim, J Hao, CC Hong, VL Bautch and S-W Jin. (2011). Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein. Nat Cell Biol 13:686-692.
3. Folkman J. (1985). Tumor angiogenesis. Adv Cancer Res 43:175-203.
4. Herbert SP and DYR Stainier. (2011). Molecular control of endothelial cell behaviour during blood vessel morphogen-esis. Nat Rev Mol Cell Biol 12:551-564.
5. Carmeliet P and RK Jain. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298-307.
6. Estrada R, N Li, H Sarojini, J An, M-J Lee and E Wang. (2009). Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J Cell Physiol 219:563-571.
7. Zacharek A, J Chen, X Cui, A Li, Y Li, C Roberts, Y Feng, Q Gao and M Chopp. (2007). Angiopoietin1/Tie2 and VEGF/ Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab 27:1684-1691.
8. Nishimori M, T Matsumoto, S Ota, S Kopf, Y Mifune, C Harner, M Ochi, FH Fu and J Huard. (2012). Role of angio-genesis after muscle derived stem cell transplantation in injured medial collateral ligament. J Orthop Res 30:627-633.
9. Rhoads RP, RM Johnson, CR Rathbone, X Liu, C Temm-Grove, SM Sheehan, JB Hoying and RE Allen. (2009). Sa-tellite cell-mediated angiogenesis in vitro coincides with a functional hypoxia-inducible factor pathway. Am J Physiol Cell Physiol 296:C1321-C1328.
10. Hakamata Y, K Tahara, H Uchida, Y Sakuma, M Nakamura, A Kume, T Murakami, M Takahashi, R Takahashi, et al. (2001). Green fluorescent protein-transgenic rat: a tool for organ transplantation research. Biochem Biophys Res Com-mun 286:779-785.
11. Son BR, LA Marquez-Curtis, M Kucia, M Wysoczynski, AR Turner, J Ratajczak, MZ Ratajczak and A Janowska-Wiec-zorek. (2006). Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264.
12. Kinnaird T, E Stabile, MS Burnett, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Marrow-derived stromal cells ex-press genes encoding a broad spectrum of arteriogenic cy-tokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685.
13. Beckert S, F Farrahi, RS Aslam, H Scheuenstuhl, A Kö-nigsrainer, MZ Hussain and TK Hunt. (2006). Lactate stim-ulates endothelial cell migration. Wound Repair Regen 14:321-324.
14. Potapova IA, GR Gaudette, PR Brink, RB Robinson, MR Rosen, IS Cohen and SV Doronin. (2007). Mesenchymal stem cells support migration, extracellular matrix invasion, pro-liferation, and survival of endothelial cells in vitro. Stem Cells 25:1761-1768.
15. Sorrell JM, MA Baber and AI Caplan. (2009). Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A 15:1751-1761.
16. Michaelis M, UR Michaelis, I Fleming, T Suhan, J Cinatl, RA Blaheta, K Hoffmann, R Kotchetkov, R Busse, H Nau and J Cinatl Jr. (2004). Valproic acid inhibits angiogenesis in vitro and in vivo. Mol Pharmacol 65:520-527.
17. Fathi E, SM Nassiri, N Atyabi, SH Ahmadi, M Imani, R Farahzadi, S Rabbani, S Akhlaghpour, M Sahebjam and M Taheri. (2012). Induction of angiogenesis via topical delivery of basic-fibroblast growth factor from polyvinyl alcohol-dextran blend hydrogel in an ovine model of acute myo-cardial infarction. J Tissue Eng Regen Med [Epub ahead of print]; DOI: 10.1002/term.1460.
18. Stieger SM, SH Bloch, O Foreman, ER Wisner, KW Ferrara and PA Dayton. (2006). Ultrasound assessment of angio-genesis in a matrigel model in rats. Ultrasound Med Biol 32:673-681.
19. Findley CM, MJ Cudmore, A Ahmed and CD Kontos. (2007). VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signal-ing. Arterioscler Thromb Vasc Biol 27:2619-2626.
20. Takakura N. (2011). Role of intimate interactions between endothelial cells and the surrounding accessory cells in the maturation of blood vessels. J Thromb Haemost 9:144-150.
21. Duffy GP, T Ahsan, T O'Brien, F Barry and RM Nerem. (2009). Bone marrow-derived mesenchymal stem cells pro-mote angiogenic processes in a time- and dose-dependent manner in vitro. Tissue Eng Part A 15:2459-2470.
22. Oskowitz A, H Mc Ferrin, M Gutschow, ML Carter and R Pochampally. (2011). Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res 6:215-225.
23. Nassiri SM, Z Khaki, M Soleimani, SH Ahmadi, I Jahanzad, S Rabbani, M Sahebjam, FA Ardalan and MS Fathollahi. (2007). The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior dif-ferentiation induction in experimental myocardial infarction. J Biomed Sci 14:745-755.
24. Menge T, M Gerber, K Wataha, W Reid, S Guha, CS Cox Jr., P Dash, MS Reitz Jr., AY Khakoo and S Pati. (2012). Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-cadherin/ß-catenin signaling pathway. Stem Cells Dev [Epub ahead of print]; DOI:10.1089/scd.2012.0165.
25. Schiltz PM, GJ Lee, JG Zhang, N Hoa, HT Wepsic, RO Dillman and MR Jadus. (2007). Human allogeneic and mu-rine xenogeneic dendritic cells are cytotoxic to human tumor cells via two distinct pathways. Cancer Biother Radiopharm 22:672-683.
26. Hergenreider E, S Heydt, K Treguer, T Boettger, AJG Hor-revoets, AM Zeiher, MP Scheffer, AS Frangakis, X Yin, et al. (2012). Atheroprotective communication between endothe-lial cells and smooth muscle cells through mi RNAs. Nat Cell Biol 14:249-256.
27. Aliotta JM, M Pereira, KW Johnson, N de Paz, MS Dooner, N Puente, C Ayala, K Brilliant, D Berz, et al. (2010). Micro-vesicle entry into marrow cells mediates tissue-specific changes in m RNA by direct delivery of m RNA and induc-tion of transcription. Exp Hematol 38:233-245.
28. Simpson RJ, JWE Lim, RL Moritz and S Mathivanan. (2009). Exosomes: proteomic insights and diagnostic potential. Ex-pert Rev Proteomics 6:267-283.
29. Villars F, B Guillotin, T Amedee, S Dutoya, L Bordenave, R Bareille and J Amedee. (2002). Effect of HUVEC on human os-teoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 282:C775-C785.
30. Badorff C, RP Brandes, R Popp, S Rupp, C Urbich, A Aicher, I Fleming, R Busse, AM Zeiher and S Dimmeler. (2003). Transdifferentiation of blood-derived human adult endo-thelial progenitor cells into functionally active cardiomyo-cytes. Circulation 107:1024-1032.
31. Formigli L, F Francini, A Tani, R Squecco, D Nosi, L Polidori, S Nistri, L Chiappini, V Cesati and A Pacini. (2005). Mor-phofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment. Am J Physiol Cell Physiol 288:C795-C804.
32. Muller-Borer BJ, WE Cascio, GL Esch, HS Kim, WB Cole-man, JW Grisham, PAW Anderson and NN Malouf. (2007). Mechanisms controlling the acquisition of a cardiac pheno-type by liver stem cells. Proc Natl Acad Sci U S A 104:3877.
33. Strassburg S, NW Hodson, PI Hill, SM Richardson and JA Hoyland. (2012). Bi-directional exchange of membrane components occurs during co-culture of mesenchymal stem cells and nucleus pulposus cells. PLoS One 7:e33739.
34. Wu Y, L Chen, PG Scott and EE Tredget. (2007). Mesench-ymal stem cells enhance wound healing through differenti-ation and angiogenesis. Stem Cells 25:2648-2659.
35. Tille J-C and MS Pepper. (2002). Mesenchymal cells poten-tiate vascular endothelial growth factor-induced angiogen-esis in vitro. Exp Cell Res 280:179-191.
36. Sung JF, X Fan, S Dhal, BK Dwyer, A Jafari, YY El-Sayed, ML Druzin and NR Nayak. (2011). Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibi-tion of vascular endothelial growth factor (VEGF) signaling. J Clin Endocrinol Metab 96:E1148-E1152.
37. Li B, EE Sharpe, AB Maupin, AA Teleron, AL Pyle, P Carmeliet and PP Young. (2006). VEGF and Pl GF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20:1495-1497.
38. Yu JX, XF Huang, WM Lv, CS Ye, XZ Peng, H Zhang, LB Xiao and SM Wang. (2009). Combination of stromal-derived factor-1 [alpha] and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. J Vasc Surg 50:608-616.
39. Watson SL, H Marcal, M Sarris, N Di Girolamo, MTC Cor-oneo and D Wakefield. (2009). The effect of mesenchymal stem cell conditioned media on corneal stromal fibroblast wound healing activities. Br J Ophthalmol 94:1067-1073.
40. Ranganath SH, O Levy, MS Inamdar and JM Karp. (2012). Harnessing the mesenchymal stem cell secretome for the treat-ment of cardiovascular disease. Cell Stem Cell 10:244-258.
41. Guérin CW and PC Holland. (1995). Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells. Dev Dyn 202:91-99.